Skip to main content
Log in

Life cycle assessment of fine chemical production: a case study of pharmaceutical synthesis

  • LCA OF CHEMICALS
  • Published:
The International Journal of Life Cycle Assessment Aims and scope Submit manuscript

Abstract

Background, aim, and scope

Pharmaceuticals have been recently discussed in the press and literature regarding their occurrence in rivers and lakes, mostly due to emissions after use. The production of active pharmaceutical ingredients (APIs) has been less analyzed for environmental impacts. In this work, a life cycle assessment (LCA) of the production of an API from cradle to factory gate was carried out. The main sources of environmental impacts were identified. The resulting environmental profile was compared to a second pharmaceutical production and to the production of basic chemicals.

Materials and methods

Detailed production data of a pharmaceutical production in Basel, Switzerland were used as the basis of this work. Information about the production of precursor chemicals was available as well. Using models and the ecoinvent database to cover remaining data gaps, a full life cycle inventory of the whole production was created. Using several life cycle impact assessment methods, including Cumulative Energy Demand (CED), Global Warming Potential (GWP), Eco-Indicator 99 (EI99), Ecological Scarcity 2006, and TRACI, these results were analyzed and the main sources of environmental burdens identified.

Results

Pharmaceutical production was found to have significantly more environmental impacts than basic chemical production in a kilogram-per-kilogram basis. Compared to average basic chemical production, the API analyzed had a CED 20 times higher, a GWP 25 times higher and an EI99 (H/A) 17 times higher. This was expected to a degree, as basic chemicals are much less complex molecules and require significantly fewer chemical transformations and purifications than pharmaceutical compounds. Between 65% and 85% of impacts were found to be caused by energy production and use. The fraction of energy-related impacts increased throughout the production process. Feedstock use was another major contributor, while process emissions not caused by energy production were only minor contributors to the environmental impacts.

Discussion

The results showed that production of APIs has much higher impacts than basic chemical production. This was to be expected given the increased complexity of pharmaceutical compounds as compared with basic chemicals, the smaller production volumes, and the fact that API production lines are often newer and less optimized than the production of more established basic chemicals. The large contributions of energy-related processes highlight the need for a detailed assessment of energy use in pharmaceutical production. The analysis of the energy-related contributions to the overall impacts on a process step level allows a comprehensive understanding of each process’ contribution to overall impacts and their energy intensities.

Conclusions

Environmental impacts of API production were estimated in a cradle-to-gate boundary. The major contributors to the environmental impacts in aggregating methods were resource consumption and emissions from energy production. Process emissions from the pharmaceutical manufacturing plant itself were less of a concern in developed countries. Producers aiming to increase their sustainability should increase efforts to reduce mass intensity and to improve energy efficiency.

Recommendations and perspectives

Pharmaceutical companies have increased their efforts to optimize resource efficiency and energy use in order to improve their environmental performance. The results of this study can be used as a first step to perform a full cradle to grave LCA of pharmaceutical production and use, which could include other important phases of the pharmaceutical product life cycle. To assess a commercial pharmaceutical, the results of API production have to be compared to the contributions of other ingredients and formulation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  • ACS (2008) American Chemical Society Green Chemistry Institute pharmaceutical roundtable. http://portal.acs.org/portal/acs/corg/content?_nfpb=true&_pageLabel=PP_TRANSITIONMAIN&node_id=1422&use_sec=false&sec_url_var=region1&__uuid=6e4e42c8-3b8f-47df-b03f-247e369debf7

  • Bare J, Norris G, Pennington D, McKone T (2003) TRACI—the tool for the reduction and assessment of chemical and other environmental impacts. J Ind Ecol 6:49–78

    Article  Google Scholar 

  • Bare J, Gloria T, Norris G (2006) Development of the method and U.S. normalization database for life cycle impact assessment and sustainability metrics. Environ Sci Technol 40:5108–5115

    Article  CAS  Google Scholar 

  • Buser HR, Poiger T, Muller MD (1999) Occurrence and environmental behaviour of the chiral pharmaceutical drug ibuprofen in surface waters and in wastewater. Environ Sci Technol 33:2529–2535

    Article  CAS  Google Scholar 

  • Capello C, Hellweg S, Badertscher B, Betschart H, Hungerbuhler K (2007a) Environmental assessment of waste-solvent treatment options. Part 1: the ecosolvent tool. J Ind Ecol 11:26–38

    Article  CAS  Google Scholar 

  • Capello C, Hellweg S, Hungerbühler K (2007b) The ecosolvent Tool. http://www.sust-chem.ethz.ch/tools/ecosolvent

  • Capello C, Hellweg S, Hungerbuhler K (2008) Environmental assessment of waste-solvent treatment options—Part II: general rules of thumb and specific recommendations. J Ind Ecol 12:111–127

    Article  Google Scholar 

  • Curzons AD, Jiménez-Gonzalez C, Duncan AL, Constable DJC, CV L (2007) Fast Life Cycle Assessment of Synthetic Chemistry (FLASC) tool. Int J LCA 12:272–280

    Article  CAS  Google Scholar 

  • DeWulf J, Bosch ME, De Meester B, Van der Vorst G, Van Langenhove H, Hellweg S, Huijbregts MAJ (2007) Cumulative exergy extraction from the natural environment (CEENE) a comprehensive life cycle impact assessment method for resource accounting. Environ Sci Technol 41:8477–8483

    Article  CAS  Google Scholar 

  • Frischknecht R, Steiner R, Braunschweig A, Egli N, Hildesheimer G (2006) Swiss ecological scarcity method: The New Version 2006

  • Goedkoop M, Spriensma R (2000) The eco-indicator 99: a damage orientated method for life-cycle impact assessment. Methodology report 2000a, Pre Consultants

  • Goedkoop M, Heijungs R, Huijbregts MAJ, De Shruyver A, Struijs J, Van Zelm R (2009) ReCiPe 2008—A life cycle impact assessment method which comprises harmonised category indicators at the midpoint and the endpoint level, http://www.lcia-recipe.net/

  • Heberer T (2002) Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. Toxicol Lett 131:5–17

    Article  CAS  Google Scholar 

  • Hischier R, Hellweg S, Capello C, Primas A (2004) Establishing life cycle inventories of chemicals based on differing data availability. Int J LCA 10:59–67

    Article  Google Scholar 

  • Huijbregts MAJ, Rombouts LJA, Hellweg S, Frischknecht R, Hendriks J, Van de Meent D, Ragas AMJ, Reijnders L, Struijs J (2006) Is cumulative fossil energy demand a useful indicator for the environmental performance of products? Environ Sci Technol 40:641–648

    Article  CAS  Google Scholar 

  • Huijbregts MAJ, Hellweg S, Frischknecht R, Hungerbuhler K, Hendriks AJ (2008) Ecological footprint accounting in the life cycle assessment of products. Ecol Econ 64:798–807

    Article  Google Scholar 

  • Jiménez-Gonzalez C (2000) Life cycle assessment in pharmaceutical applications. PhD thesis, North Carolina State University, Raleigh, NC

  • Jiménez-Gonzalez C, Curzons AD, Constable DJC, VL C (2004) Cradle-to-gate life cycle inventory and assessment of pharmaceutical compounds. Int J LCA 9:114–121

    Article  Google Scholar 

  • Jodicke G, Fischer U, Hungerbuhler K (2001) Wastewater reuse: a new approach to screen for designs with minimal total costs. Comput Chem Eng 25:203–215

    Article  CAS  Google Scholar 

  • Jolliet O, Margni M, Charles R, Humbert S, Payet J, Rebitzer G, Rosenbaum R (2003) IMPACT 2002+: a new life cycle impact assessment methodology. Int J LCA 8:324–330

    Article  Google Scholar 

  • Köhler A, Hellweg S, Recan E, Hungerbühler K (2007) Input-dependent life-cycle inventory model of industrial wastewater-treatment processes in the chemical sector. Environ Sci Technol 41:5515–5522

    Article  Google Scholar 

  • Kummerer K (2008) Pharmaceuticals in the Environment. Springer, Berlin

    Book  Google Scholar 

  • Loffler D, Rombke J, Meller M, Ternes TA (2005) Environmental fate of pharmaceuticals in water/sediment systems. Environ Sci Technol 39:5209–5218

    Article  Google Scholar 

  • Mutel C, Kestenholz M (2008) The Brightway LCA model. http://brightwaylca.org

  • Rosenbaum RK, Bachmann TM, Gold LS, Huijbregts MAJ, Jolliet O, Juraske R, Koehler A, Larsen HF, MacLeod M, Margni M, McKone TE, Payet J, Schuhmacher M, van de Meent D, Hauschild MZ (2008) USEtox—the UNEP–SETAC toxicity model: recommended characterisation factors for human toxicity and freshwater ecotoxicity in life cycle impact assessment. Int J LCA 13:532–546

    Article  CAS  Google Scholar 

  • Sheldon RA (1994) Consider the environmental quotient. Chemtech 24:38–47

    CAS  Google Scholar 

  • Szijjarto A, Papadokonstadakis S, Fischer U, Hungerbühler K (2008) Bottom-up modelling of the steam consumption in multipurpose chemical batch plants focusing on identification of the optimization potential. Ind Eng Chem Res 47:7323–7334

    Article  CAS  Google Scholar 

  • The ecoinvent centre (2008a) Ecoinvent 2.01 database. http://www.ecoinvent.ch

  • The ecoinvent centre (2008b) Ecoinvent 2.01 Reports, Chapter 1: Overview and Methodology

  • The Intergovernmental Panel on Climate Change (2007) Fourth Report. Climate Change 2007. http://www.ipcc.ch/ipccreports/ar4-wg1.htm

  • Thieme Chemistry (2009) Römpp Online. http://www.roempp.com

  • Ullmann's Encyclopedia of Industrial Chemistry 2006: 7th Electronic Edition. http://www.mrw.interscience.wiley.com/ueic/. Wiley, Weinheim

  • Verein Deutscher Ingenieure (1997) VDI-richtlinie 4600: cumulative energy demand, terms, definitions, methods of calculation. Verein Deutscher Ingenieure, Düsseldorf

    Google Scholar 

  • Wernet G, Hellweg S, Fischer U, Papadokonstantakis S, Hungerbuhler K (2008) Molecular-structure-based models of chemical inventories using neural networks. Environ Sci Technol 42:6717–6722

    Article  CAS  Google Scholar 

  • Wernet G, Papadokonstantakis S, Hellweg S, Hungerbuhler K (2009) Bridging data gaps in environmental assessments: modelling impacts of fine and basic chemical production. Green Chem 11:1826–1831

    Google Scholar 

Download references

Acknowledgments

The authors would like to thank the Swiss Federal Office for the Environment (project no. 810.3189.004) and the Swiss Federal Office for Energy (project no. 101711) for their support on this project.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gregor Wernet.

Additional information

Responsible editor: Roland Hischier

Electronic supplementary materials

ESM 1

ESM 1 (DOC 31 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wernet, G., Conradt, S., Isenring, H.P. et al. Life cycle assessment of fine chemical production: a case study of pharmaceutical synthesis. Int J Life Cycle Assess 15, 294–303 (2010). https://doi.org/10.1007/s11367-010-0151-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11367-010-0151-z

Keywords

Navigation